Managing Lifecycle Complexity: Controlling Compliance Risk and Operational Pressure Across Regulatory and Pharmacovigilance
As pharmaceutical organizations grow and evolve, Lifecycle Management becomes increasingly difficult to control. This webinar explores how complexity develops across Regulatory Affairs and Pharmacovigilance, and how to structure activities in a more scalable and cost-efficient way.
In today's pharmaceutical environment, Lifecycle Management is no longer only a regulatory or pharmacovigilance challenge, it is an operational challenge.
As organizations grow internationally, add products, integrate acquisitions, or expand into multiple markets, both Regulatory Affairs and Pharmacovigilance teams face increasing operational complexity. Activities become more interconnected, coordination becomes more difficult, and pressure grows to maintain compliance while controlling workload, timelines, costs, and operational risk.
This webinar explores how these challenges develop across three common operational scenarios:
- Integration of new product types where internal expertise is limited
- Growing portfolios with constrained internal resources
- Expansion into new markets with limited local knowledge or operational capacity
For each scenario, we will connect operational complexity with its impact on variations, submissions, safety reporting, compliance oversight, and cross-functional coordination.
The session will also highlight:
- Loss of control — Where lifecycle execution typically starts to lose control
- Emerging risks — What risks emerge in terms of compliance, timelines, data consistency, and operational efficiency
- Scalable structure — How organizations can structure Lifecycle Management activities in a more scalable and cost-efficient way
We will conclude with case studies showing how an integrated Lifecycle Management approach helped stabilize operations, reduce complexity, and improve efficiency and cost control across Regulatory and Pharmacovigilance functions.
What you'll learn
- How operational complexity, workload, and compliance pressure develop across Regulatory Affairs and Pharmacovigilance activities
- How common business scenarios impact variations, submissions, safety reporting, and cross-functional coordination
- Where Lifecycle Management activities typically become inefficient or difficult to control
- How to improve operational efficiency while maintaining compliance and managing resource constraints
- How integrated Regulatory and PV approaches can support more scalable and cost-efficient operating models
- Practical lessons from real-life cases where Lifecycle Management complexity was successfully managed